Kevin Kelly
Family Medicine · Russellville, ALNPI 1710972385
Payments from drug & device makers
Across 228 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$672
- Pfizer$447
- Lilly USA, LLC$399
- Johnson & Johnson$316
- Bayer$312
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,588100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $1,324 |
| AstraZeneca | 29 | $672 |
| Pfizer | 39 | $447 |
| Lilly USA, LLC | 22 | $399 |
| Johnson & Johnson | 10 | $316 |
| Bayer | 16 | $312 |
| Novartis | 9 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $153 |
| AbbVie(2 entities) | 9 | $128 |
| GSK | 7 | $120 |
| Amgen | 6 | $81 |
| Merck | 5 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Genentech USA, Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $33 |
| Boehringer Ingelheim | 2 | $33 |
| BD | 1 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Corium, LLC | 4 | $30 |
| Exact Sciences | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
| Evoke Pharma, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,588 in reported general payments places this provider in the 80th percentile of 1,680 family medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 224 | $147,377 |
| FarxigaDapagliflozin Propanediol | 146 | $76,069 |
| MounjaroTirzepatide | 59 | $65,575 |
| XifaxanRifaximin | 22 | $48,917 |
| OzempicSemaglutide | 29 | $48,251 |
| JardianceEmpagliflozin | 53 | $42,715 |
| DapagliflozinDapagliflozin Propanediol | 62 | $27,058 |
| LinzessLinaclotide | 34 | $22,257 |
| TrulicityDulaglutide | 16 | $20,178 |
| MyrbetriqMirabegron | 33 | $18,673 |
| JanuviaSitagliptin Phosphate | 23 | $16,152 |
| BriviactBrivaracetam | 16 | $13,023 |
| EntrestoSacubitril/Valsartan | 20 | $12,498 |
| BrilintaTicagrelor | 16 | $8,717 |
| XareltoRivaroxaban | 19 | $8,599 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $447 | $147,377224 claims |
| AstraZenecaFarxiga, Brilinta, Lokelma, Symbicort | $672 | $97,967190 claims |
| Lilly USA, LLCMounjaro, Trulicity | $399 | $85,75475 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $62 | $48,91722 claims |
| Novo NordiskOzempic | $1,324 | $48,25129 claims |
| Boehringer IngelheimJardiance | $33 | $42,71553 claims |
| AbbVieLinzess | $128 | $22,25734 claims |
| MerckJanuvia | $72 | $16,15223 claims |
| NovartisEntresto | $188 | $12,49820 claims |
| Johnson & JohnsonXarelto | $316 | $8,59919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Russellville
- Michael VaughnBirmingham$9.9M
- William NixonGuntersville$7.1M
- Randall QuinnCullman$5.4M
- Matthew CaldwellAthens$4.1M
- Michael CarterHuntsville$3.4M
- Howard RubensteinSaraland$3.3M
- Randle MiddletonHuntsville$3.3M
- Aaron KarrSheffield$3.1M
- Nidal MorrarFoley$3M
- Timothy HowardHuntsville$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.